Avanos Medical (AVNS) Stock Analysis & Winston Score
Avanos Medical is a medical device company that makes products to help patients manage pain and recover from illness or surgery. Its main products include nerve block systems for pain relief, feeding tubes, and airway management devices used in hospitals and clinics. The company spun off from Halyard Health in 2018 and focuses on what it calls "pure-play" pain management and recovery solutions. Avanos earns money by selling these medical devices to hospitals, surgery centers, and healthcare providers, primarily in the United States but also in some international markets. The company generates roughly $700–800 million in annual revenue, but its negative operating and return margins show it is currently spending more than it earns from operations. The key challenge ahead is returning to profitability while facing competition from larger medical device companies like Medtronic and Becton Dickinson, which have significantly more resources and broader product portfolios.
Winston Score: 26/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (11/30)
- Growth: Weak (4/20)
- Cash Flow: Weak (1/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Mixed (4/15)
Key Facts
Price: $24.97
Market Cap: $1.2B
Sector: Healthcare
Industry: Medical - Devices

